Company intelligence / Profile preview

C.O. Truxton

Bellmawr, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

C.O. Truxton is a pharmaceutical company focused on the distribution and repackaging of generic prescription drugs and over-the-counter (OTC) products. The company serves a variety of healthcare providers, including physicians, clinics, and pharmacies, by providing a broad range of essential medications. Their product portfolio typically includes analgesics, cardiovascular treatments, and nutritional supplements. C.O. Truxton operates primarily as a wholesaler and repackager, ensuring that healthcare facilities have access to cost-effective generic alternatives.

Therapeutic areas: EndocrinologyCardiovascularNeurologyMetabolic Disorders
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on C.O. Truxton.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on C.O. Truxton.

Explore the full profile